Back to User profile » Dr Kan Liu
Papers published by Dr Kan Liu:
Original Research
Identification of a Prognostic Gene Signature Based on Lenvatinib Resistance in Hepatocellular Carcinoma with Functional Validation of the Key Gene CPB2
Liu K, Cheng F, Li C, Cheng S, Wei J, Wu J, Huang S
Journal of Hepatocellular Carcinoma 2026, 13:579244
Published Date: 14 May 2026
Original Research
Establishment and Validation of a Novel Nutritional-Immune-Inflammatory Score Model for Predicting Survival Prognosis in Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
Liu K, Lv Y, Fu S, Mao Y, Xu Y, Huang S, Wu J
Journal of Inflammation Research 2025, 18:13397-13412
Published Date: 27 September 2025
Original Research
Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
Xu Y, Fu S, Liu K, Mao Y, Wu J
Therapeutics and Clinical Risk Management 2023, 19:853-863
Published Date: 24 October 2023
Original Research
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
Liu K, Wu J, Xu Y, Li D, Huang S, Mao Y
OncoTargets and Therapy 2022, 15:1079-1094
Published Date: 1 October 2022